Updated Jul 16, 2026
Winslow Garrett has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $14K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | DMRA | Damora Therapeutics, Inc. | S — Open-market sale | 245 | $29.98 | $7K |
| 2026-07-08 | DMRA | Damora Therapeutics, Inc. | M — Option exercise | 680 | — | |
| 2026-01-06 | DMRA | Damora Therapeutics, Inc. | S — Open-market sale | 255 | $21.38 | $5K |
| 2026-01-06 | DMRA | Damora Therapeutics, Inc. | M — Option exercise | 680 | — | |
| 2025-07-03 | DMRA | Damora Therapeutics, Inc. | S — Open-market sale | 260 | $3.39 | $881 |
| 2025-07-03 | DMRA | Damora Therapeutics, Inc. | M — Option exercise | 680 | — |
Winslow Garrett is a corporate insider — currently tracked as Insider of Damora Therapeutics, Inc. (DMRA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($14K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Winslow Garrett profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.